From Discovery to Delivery: COVID-19 Vaccine Strategy
Presented by Johns Hopkins Carey Business School and the Hopkins Business of Health Initiative
The development and deployment of an effective vaccine for COVID-19 could be the turning point in the fight against the deadly pandemic. Join our distinguished panel of public health experts and vaccine industry executives for an engaging discussion examining every aspect of the COVID-19 vaccine from discovery to manufacturing to delivery.
Bill Enright is chief executive officer of Vaccitech, a strategic partner with AstraZeneca in developing one of the first COVID-19 vaccine candidates. He is also a graduate of Johns Hopkins Carey Business School and a member of the Dean’s Advisory Board.
Reed Tuckson, MD, FACP, is managing director of Tuckson Health Connections, LLC, and a member of the Berman Institute of Bioethics’ National Advisory Board. Previously he was executive vice president and chief of medical affairs for United Health Group and commissioner of public health for Washington, D.C.
Abigail Jenkins is senior vice president and vaccine business unit head for Emergent BioSolutions. Emergent BioSolutions is working with AstraZeneca on the manufacturing and deployment of the COVID-19 vaccine.
Daniel Polsky, PhD, is Bloomberg Distinguished Professor in Health Economics at Johns Hopkins Carey Business School and Johns Hopkins Bloomberg School of Public Health. He also directs the Hopkins Business of Health Initiative and will serve as moderator of the panel.